BGM
Qilian International Holding Group LimitedNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$66.85M
P/E Ratio
—
EPS
$-0.29
Beta
1.46
52W High
$17.17
52W Low
$0.27
50-Day MA
$1.30
200-Day MA
$6.46
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Qilian International Holding Group Limited
Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company is headquartered in Jiuquan, the People's Republic of China.
Fundamentals
| Revenue (TTM) | $29.87M |
| Gross Profit (TTM) | 870,770 |
| EBITDA | $-2.37M |
| Operating Margin | -15.60% |
| Return on Equity | -16.50% |
| Return on Assets | -3.84% |
| Revenue/Share (TTM) | $4.18 |
| Book Value | $1.85 |
| Price-to-Book | 0.37 |
| Price-to-Sales (TTM) | 0.24 |
| EV/Revenue | 2.043 |
| EV/EBITDA | -2.48 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 13.90% |
| Shares Outstanding | $180.62M |
| Float | $2.83M |
| % Insiders | 63.68% |
| % Institutions | 0.17% |
Data last updated: 4/7/2026